Products for Research Use Only
RegisterLogin

SGP8

CAT: 0804-HY-P6177Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P6177Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SGP8 (IAVPGEVA) is an octapeptide produced by hydrolysis of soybean 11S globulin, which has the effects of regulating lipid metabolism, inflammation and fibrosis. SGP8 (IAVPGEVA) exhibits inhibitory activity against DPP4 and inhibits the JNK-c-Jun signaling pathway, and has the ability to inhibit non-alcoholic steatohepatitis (NASH) [1].
CAS Number
855790-98-6
UNSPSC
12352209
Target
Dipeptidyl Peptidase
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sgp8.html
Solubility
10 mM in DMSO
Smiles
N[C@]([C@@H](C)CC)([H])C(N[C@@H](C)C(N[C@@H](C(C)C)C(N1CCC[C@H]1C(NCC(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](C)C(O)=O)=O)=O)CCC(O)=O)=O)=O)=O)=O)=O
Molecular Formula
C34H58N8O11
Molecular Weight
754.87
References & Citations
[1]Peng Ma, et al. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis.Journal of Agricultural and Food Chemistry. 2024, 72, 13, 7167–7178.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
DPP-4

Related Products

CatalogName
HY-P991245Anti-ERBB3/HER3 (SGP1)

Alternative Products

CatalogName
T87384-01SGP8

Popular Products